Survival Modeling with Weibull: Why am I overestimating the effect size in my simulation?
|
|
11
|
373
|
March 14, 2025
|
Recombining survival curves when stratifying a time varying categorical variable what is the best practice
|
|
1
|
182
|
March 12, 2025
|
Cox.zph after survSplit aregImpute and fit.mult.impute
|
|
1
|
195
|
February 25, 2025
|
Differences in Confidence Intervals in Cox Model Predictions
|
|
1
|
201
|
February 25, 2025
|
Internal variables with a heavy boundary of zero
|
|
6
|
412
|
February 25, 2025
|
Forest Plot of HRs in subgroups in Cox model
|
|
8
|
609
|
February 4, 2025
|
How to rank parameters and choose "the best"?
|
|
14
|
808
|
January 18, 2025
|
Summary table of different Cox PHM models to compare them
|
|
7
|
915
|
December 23, 2024
|
How to use parameters of different measurement times?
|
|
3
|
455
|
December 18, 2024
|
RMS Cox PH Model
|
|
51
|
5197
|
November 21, 2024
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
6
|
8431
|
November 5, 2024
|
RMS Case Study in Cox Regression
|
|
4
|
16469
|
September 28, 2024
|
Dynamic regression for survival analysis
|
|
0
|
648
|
September 18, 2024
|
Andersen-Gill - multistate and time varying covariate
|
|
6
|
992
|
August 27, 2024
|
C-index with clustered data
|
|
1
|
745
|
August 8, 2024
|
Marginal Structural Models
|
|
2
|
753
|
July 25, 2024
|
Progression in cancer trials
|
|
26
|
5483
|
June 25, 2024
|
External validation of a time-to-event prognostic model
|
|
2
|
1163
|
May 2, 2024
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
1234
|
April 17, 2024
|
Numerical Differences in Survival Probability Estimates between coxph and cph Functions
|
|
8
|
1406
|
March 24, 2024
|
Validate and calibrate Cox model on dataset with a categorical covariate with few observations
|
|
2
|
1209
|
March 21, 2024
|
External Validation and Calibration of Cox model
|
|
13
|
7289
|
March 12, 2024
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
847
|
March 10, 2024
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
1041
|
February 23, 2024
|
Time to pre-randomization monthly seizure count
|
|
1
|
968
|
February 8, 2024
|
Creating a Nomogram with Multiply Imputed Datasets
|
|
1
|
1237
|
January 31, 2024
|
Use of cpower function in Hmisc package
|
|
4
|
1447
|
January 9, 2024
|
Calculating fraction of new information in Cox proportional hazard models
|
|
17
|
2437
|
December 14, 2023
|
Combining HR from same study sub-groups for meta-analysis
|
|
0
|
928
|
November 28, 2023
|
Immortal time bias
|
|
2
|
1002
|
October 29, 2023
|